Katia Christina Genadry, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eye Injuries | 1 | 2021 | 227 | 0.620 |
Why?
|
| Antifibrinolytic Agents | 1 | 2021 | 292 | 0.600 |
Why?
|
| Radius | 1 | 2020 | 441 | 0.580 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2021 | 807 | 0.480 |
Why?
|
| Radius Fractures | 1 | 2020 | 515 | 0.480 |
Why?
|
| Rhabdomyosarcoma, Alveolar | 2 | 2021 | 42 | 0.330 |
Why?
|
| Migraine Disorders | 1 | 2022 | 1703 | 0.330 |
Why?
|
| Opioid-Related Disorders | 1 | 2022 | 2164 | 0.280 |
Why?
|
| Hyphema | 1 | 2021 | 26 | 0.190 |
Why?
|
| Receptors, Notch | 1 | 2021 | 744 | 0.130 |
Why?
|
| Diagnostic Errors | 1 | 2020 | 1265 | 0.110 |
Why?
|
| Neoplastic Stem Cells | 1 | 2021 | 1351 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2021 | 2827 | 0.100 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 3358 | 0.070 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 3808 | 0.060 |
Why?
|
| Physicians | 1 | 2023 | 4591 | 0.060 |
Why?
|
| Child | 3 | 2023 | 80158 | 0.060 |
Why?
|
| Emergency Service, Hospital | 1 | 2022 | 7879 | 0.050 |
Why?
|
| Incidence | 1 | 2020 | 21355 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2020 | 26202 | 0.040 |
Why?
|
| Accreditation | 1 | 2023 | 473 | 0.040 |
Why?
|
| Infant | 1 | 2020 | 36193 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2018 | 12130 | 0.040 |
Why?
|
| Child, Preschool | 1 | 2020 | 42232 | 0.040 |
Why?
|
| Signal Transduction | 1 | 2021 | 23447 | 0.040 |
Why?
|
| Myoblasts | 1 | 2018 | 231 | 0.030 |
Why?
|
| Acyltransferases | 1 | 2018 | 305 | 0.030 |
Why?
|
| Humans | 6 | 2023 | 761596 | 0.030 |
Why?
|
| Educational Status | 1 | 2023 | 2522 | 0.030 |
Why?
|
| Young Adult | 1 | 2022 | 59260 | 0.030 |
Why?
|
| Adolescent | 1 | 2022 | 88326 | 0.030 |
Why?
|
| Cell Proliferation | 2 | 2021 | 10451 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2021 | 8554 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 1668 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2022 | 80647 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2021 | 16990 | 0.030 |
Why?
|
| Female | 2 | 2022 | 392705 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2018 | 1756 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2018 | 2932 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2018 | 2856 | 0.020 |
Why?
|
| Adult | 1 | 2022 | 221210 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 9420 | 0.020 |
Why?
|
| Male | 1 | 2020 | 360846 | 0.010 |
Why?
|
| Apoptosis | 1 | 2018 | 9490 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 18255 | 0.010 |
Why?
|
| Mice | 1 | 2018 | 81539 | 0.010 |
Why?
|
| Animals | 1 | 2018 | 168475 | 0.000 |
Why?
|